Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer By Ogkologos - April 16, 2026 175 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a phase III study in patients recruited through the PATCH and STAMPEDE-1 trial networks Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Teclistamab ESMO Launches Clinical Trials Funding Initiative to Optimise Cancer Care Pathways FDA Approves Gedatolisib with Fulvestrant, With or Without Palbociclib, for HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR El cáncer en mi comunidad: Cómo superar las desigualdades en la... January 3, 2023 Group of Breast Cancer Survivors is Finding New Strength from Fitness... May 11, 2021 EMA Recommends Extension of Indications for Talazoparib November 27, 2023 Makeup Artist Gives Breast Cancer Survivors Free Makeovers January 6, 2021 Load more HOT NEWS Veteran and His Loyal Dog Pass Away Within Hours Of Each... Cancer in My Community: Providing Supportive Care in Serbia Adjuvant Chemotherapy Customisation Based on ERCC1 and TS mRNA Levels Does... FDA Approves Neoadjuvant/Adjuvant Nivolumab for Resectable Non-Small Cell Lung Cancer
